An Internal Failure To Innovate Is America's Greatest Global Threat - Biopharmaceuticals

"The $900 billion U.S. biopharmaceutical industry is a critical force in the U.S. economy. It supports some four million American jobs, including more than 650,000 jobs in the industry itself. The average biopharma wage is nearly twice the U.S. private sector average, $119,000 versus $64,000 – reflecting the value created by pharmaceutical innovation."

An Internal Failure To Innovate Is America's Greatest Global Threat - Forbes:

"Just this month, we learned that the U.S. dropped to 10th place in the 2012 Global Innovation Index, down from 7th place the year before. The index, published by the international business school INSEAD and the World Intellectual Property Organization, ranks 141 nations on nearly 100 factors related to innovation; the top two countries, for two years running, are Switzerland and Sweden.

The report said the biggest area of concern for the U.S. was a drop in “human capital and research” – which includes K-12 and college education, as well as R&D.  In these areas so critical to future innovation, the U.S. ranking fell from 13th in 2011 to 22nd this year."

'via Blog this'